I believe there's an error in the way the amendment is written and that it is really meant to say “lines 20 to 24” instead of “lines 18 to 22”, I guess. It's only touching on the definition, that was the only thing. Because we now have a new schedule 1 that contains a list, and the list is based on the new definition, the one that I'm proposing here for “pharmaceutical product”, which was really what used to be there in the Patent Act anyway.
On October 28th, 2010. See this statement in context.